CE Stock Recent News
CE LATEST HEADLINES
Celanese (CE) achieves milestones in cost-effective, sustainable growth, including new facilities and supply contracts, positioning for earnings increase and global expansion.
Celanese (CE) benefits from its productivity measures, investments in organic projects and strategic acquisitions.
Celanese (CE) now offers low-carbon choices to customers across its Acetyl Chain and Engineered Materials products under the ECO-CC name.
Celanese's (CE) collaboration with Secarna enables the development of a novel implant with the potential to significantly alter how disease-modifying ASO treatments are given.
Celanese (CE) reported earnings 30 days ago. What's next for the stock?
While Celanese (CE) faces headwinds from demand softness and pricing pressures, it gains on strategic acquisitions and productivity measures.
Celanese's acquisition of DuPont's Mobility and Materials division did not bring the expected returns due to a challenging market environment. The company is currently saddled with a large debt and depressed earnings, but management is taking actions to ensure profitability and service the debt. While management is taking the right actions, the current perspective does not outweigh short-term risks.
iDose TR uses Celanese's (CE) VitalDose EVA. It is approved following the completion of two pivotal trials which demonstrates safety and efficacy.
Celanese Corporation (CE) Q4 2023 Earnings Call Transcript
Pricing of Celanese's (CE) Engineered Material segment declines in Q4 due to tough competition and product mix challenges in the Americas and Europe.